RE: RNS - worrying18 Sep 2024 15:56
“Where has the money to pay for two clinical trials gone? "
That's news to me. Is the money gone?”
Fruits, the cash that Simon Shaw boasted we had in June 2022 to run multiple trials, that a year later we now can’t afford a single trial. Close to £8m down as at 31/12/23 and presumably a fair bit lower than that 9 months on.
“Cash and cash equivalents, and bank deposits of £12.0 million at 31 December 2023 (31 December 2022: £19.7 million)”
It’s all in the recent annual results RNS, including this vital part way down towards the bottom in the going concern section:
“The directors have identified that the Group will need to raise further funds during 2024 in order to conduct the planned Phase 2 clinical trial in mechanically ventilated patients. The ability of the Group to secure a fund raise in 2024 cannot be guaranteed…”
Very clearly, they have stated they need to raise funds. Money isn’t free, as much as my wife likes to think it is.